For the Inventor, By the Inventor

Enter assignee name

San Jose, CA, United States of America

Rani Therapeutics, LLC

Calculating rank

USPTO Granted Patents = 97

% Expired Patents = 6.2

CIPO Patents = 2

EPO Patents = 11

Trademarks = 6

Forward Citations = 4,404

Loading Chart...

Loading Chart...

16 inventors (with patents filed for the assignee):

Mir A Imran (95 out of 449 patents)

Mir Hashim (12 out of 37 patents)

Radhika Korupolu (11 out of 21 patents)

4. Joel M Harris (6 out of 21 patents)

5. Mercedes Morales (5 out of 11 patents)

6. Peter Herrmann (5 out of 5 patents)

7. Timothy H Williams (5 out of 11 patents)

8. Chang Jin Ong (5 out of 10 patents)

9. Greg Method (5 out of 5 patents)

10. Baber R Syed (5 out of 9 patents)

11. Sara Ansaloni (4 out of 4 patents)

12. Elaine To (3 out of 5 patents)

13. Mir A Imran (2 out of 3 patents)

14. Emily Arnsdorf (1 out of 9 patents)

15. Anusha Garapaty (0 patent)

Core Competencies:

Swallowable Device

Drug Delivery

Therapeutic Agents

Insulin Delivery

Polypeptides

Gonadotropin

Exenatide

Somatostatin

Etanercept

Clotting Factors

Incretin Production

Oral Delivery

97 patents: Sort by Forward Citations

1. 12642947 - Injection of a therapeutic formulation into a wall of the gastrointestinal tract (2026-06-02),

2. 12268831 - Swallowable drug delivery device and methods of drug delivery (2025-04-08),

3. 12263325 - Device, system and methods for the oral delivery of therapeutic compounds (2025-04-01),

4. 12214019 - Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins (2025-02-04),

5. 12201721 - Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device (2025-01-21),

6. 12128133 - Ingestible device with expandable enclosure (2024-10-29),

7. 12018090 - PCSK9 antibody preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device (2024-06-25),

8. 11844867 - Method of delivering insulin into a lumen of the intestinal tract using a swallowable drug delivery device (2023-12-19),

9. 11833319 - Propulsive drug delivery from a swallowable device into a patients intestinal tract (2023-12-05),

10. 11826464 - Clotting factor preparations for delivery into tissue of the intestinal tract using a swallowable drug delivery device (2023-11-28),

11. 11814427 - Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device (2023-11-14),

12. 11813314 - Method of delivering a somatostatin compound into a lumen of the intestinal tract using a swallowable drug delivery device (2023-11-14),

13. 11806504 - Device, system and methods for the oral delivery of therapeutic compounds (2023-11-07),

14. 11771879 - Therapeutic agent preparations for delivery into a lumen of the intestinal tract using a swallowable drug delivery device (2023-10-03),

15. 11718665 - Pharmaceutical compositions and methods for fabrication of solid masses comprising polypeptides and/or proteins (2023-08-08),

Company Overview

Rani Therapeutics, LLC, based in San Jose, CA, specializes in innovative swallowable drug delivery systems. The company focuses on developing advanced technologies that enable the oral administration of therapeutic agents, including insulin and various polypeptides. By leveraging its proprietary swallowable device platform, Rani aims to enhance patient compliance and improve the efficacy of treatments for conditions requiring injectable medications. Its research encompasses a range of therapeutic areas, including diabetes and hormone therapies.

Profile summary synthesized from public USPTO records and patent filings.

Company Badge

USPTO Data Jan 1 1976 - Nov 3 2026

97 Patents

#114 in San Jose, CA

#905 in California

#3,892 in US

#7,982 in the World

San Jose, CA, United States of America

Rani Therapeutics, LLC

Forward Citations = 4,404

16 inventors:

Mir A Imran (95 out of 449 patents)

Mir Hashim (12 out of 37 patents)

Radhika Korupolu (11 out of 21 patents)

4. Joel M Harris (6 out of 21 patents)

5. Mercedes Morales (5 out of 11 patents)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Rani Therapeutics, LLC. Retrieved from https://idiyas.com/company/rani-therapeutics

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

Loading…